logo-loader
Integumen

Full interview: Integumen PLC well funded as it continues growth towards profitability

Integumen PLC (LON:SKIN) CEO Gerry Brandon talks Proactive London's Andrew Scott through the firm's first half numbers.

Revenues from continuing operations had increased 540% to £346,697, while its EBITDA loss had fallen 32% to £370,102.

That doesn't include RinoCloud revenues of £178,000 from January 2019 - April 2019.

Brandon says the current level of activity in the pipeline's significantly higher than they've seen in the past and demand for its products and services has continued to increase.

Quick facts: Integumen

Price: £0.02

Market: AIM
Market Cap: £16.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: CBD deal for Integumen and Highlands Natural Resources

Top stories from the Proactive Investors UK newsroom. Power Metal Resources (LON:POW) has taken an option over 70% of a cobalt and copper licence to the north and east of the Tondo cobalt-copper mine in the DRC. Highlands Natural (LON:HNR) has entered into a two-year agreement to provide...

on 2/8/19

2 min read